Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life

Journal of Nutrition

Volumn 138, Issue 6, 2008, Pages 1091-1095

  Arslanoglu, Sertac ^a   Moro, Guido E ^a   Schmitt, Joachim ^b   Tandoi, Laura ^a   Rizzardi, Silvia ^a   Boehm, Gunther ^b,c  

^a UNIVERSITY OF MILAN   (Italy)

^b Numico Research   (Germany)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FRUCTOSE OLIGOSACCHARIDE PLUS GALACTOSE OLIGOSACCHARIDE; IMMUNOFORTIS; PLACEBO; PREBIOTIC AGENT;

ALLERGIC URTICARIA; ARTICLE; ATOPIC DERMATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FEMALE; FOLLOW UP; HUMAN; IMMUNOMODULATION; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; UPPER RESPIRATORY TRACT INFECTION; WHEEZING;

EID: 44449168636     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/138.6.1091     Document Type: Article

References (48)

1. Eiwegger T, Stahl B, Schmitt JJ, Boehm G, Gerstmayr M, Pichler J, Dehlinek E, Urbanek R, Sze'pfalusi Z. Human milk derived oligosaccharides and plant derived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro. Pediatr Res. 2004;56:536-40.
2. Velupillai P, Harn DA. Oligosaccharide-specific induction of interleukin 10 production by B2201 cells from schistosome-infected mice: a mechanism for regulation of CD41 T-cell subsets. Proc Natl Acad Sci USA. 1994;91:18-22.
3. Schumacher G, Bendas G, Stahl B, Beermann C. Human milk oligosaccharides affect P-selectin binding capacities: in vitro investigation. Nutrition. 2006;22:620-7.
4. Bode L, Rudloff S, Kunz C, Strobel S, Klein N. Human milk oligosaccharides reduce platelet-neutrophil complex formation leading to a decrease in neutrophil b 2 integrin expression. J Leukoc Biol. 2004;76:820-6.
5. Naarding MA, Ludwig IS, Groot F, Berkhout B, Geijtenbeek TB, Pollakis G, Paxton VA. Lewis X-component in human milk binds DCSIGN and inhibits HIV-1 transfer to CD41 lymphocytes. J Clin Invest. 2005;115:3256-64.
6. Boehm G, Stahl B. Oligosaccharides from milk. J Nutr. 2007;137:S847-9.
7. Boehm G, Stahl B. Oligosaccharides. In: Mattila-Sandholm T, editor. Functional dairy products. Cambridge: Woodhead Publishing; 2003. p. 203-43.
8. Bode L. Recent advances on structure, metabolism, and function of human milk oligosaccharides. J Nutr. 2006;136:2127-30.
9. Boehm G, Fanaro S, Jelinek J, Stahl B, Marini A. Prebiotic concept for infant nutrition. Acta Paediatr Suppl. 2003;91:64-7.
10. Boehm G, Lidestri M, Casetta P, Jelinek J, Negretti F, Stahl B, Marini A. Supplementation of an oligosaccharide mixture to a bovine milk formula increases counts of faecal bifidobacteria in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2002;86:F178-81.
11. Moro G, Minoli I, Mosca M, Fanaro S, Jelinek J, Stahl B, Boehm G. Dosage related bifidogenic effects of galacto- and fructo oligosaccharides in formula fed term infants. J Pediatr Gastroenterol Nutr. 2002;34:291-5.
12. Schmelzle H, Wirth S, Skopnik H, Radke M, Knol J, Böckler HM, Brönstrup A, Wells J, Fusch C. Randomised double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high beta palmitic acid level, and nondigestible oligosaccharides. J Pediatr Gastroenterol Nutr. 2003;36:343-51.
13. Knol J, Scholtens B, Kafka C, Steenbakkers J, Gro S, Helm K, Klarczyk M, Schöpfer H, Böckler HM, et al. Colon microflora in infant fed formula with galacto- and fructo-oligosaccharides: more like breast fed infants. J Pediatr Gastroenterol Nutr. 2005;40:36-42.
14. Neu J, Douglas-Escobar M, Lopez M. Microbes and the developing gastrointestinal tract. Nutr Clin Pract. 2007;22:174-82.
15. Corthésy B, Gaskins HR, Mercenier A. Cross-talk between probiotic bacteria and the host immune system. J Nutr. 2007;137:S781-90.
16. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis durig the first six months of age. Arch Dis Child. 2006;91:814-9.
17. Arslanoglu S, Moro G, Boehm G. Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. J Nutr. 2007;137:2420-4.
18. Harrigan E, Rabinowitz LG. Atopic dermatitis. Immunology and Allergy Clinics of North America. 1999;19:383-96.
19. Muraro A, Dreborg S, Halken S, Host A, Niggemann B, Aalberse R, Arshad SH, von Berg A, Karlsen KH, et al. Dietary prevention of allergic diseases in infants and small children. Part II: evaluation of methods in allergy prevention studies and sensitization markers. Definitions and diagnostic criteria for allergic diseases. Pediatr Allergy Immunol. 2004;15:196-205.
20. Kunz B, Oranje AP, Labrèze L, Stalder JF, Ring J, Taïeb A. Clinical validation and guidelines for the SCORAD index: Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195:10-9.
21. Anonymous. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology. 1993;186:23-31.
22. von Berg A, Koletzko S, Grübl A, Filipiak-Pittroff B, Wichmann HE, Bauer CP, Reinhardt D, Berdel D, German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double-blind trial. J Allergy Clin Immunol. 2003;111:533-40.
23. Rautava S. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol. 2002;109:119-21.
24. Vandenplas Y. Clinical overview the changing pattern of clinical aspects of allergic diseases. In: Isolauri E, Walker WA, editors. Allergic diseases and the environment. Nestlé Nutrition Workshop Series Pediatric Program. Basel (Switzerland): Nestec Ltd Vevey/S. Karger AG; 2004. pp 1-25.
25. Kuehni CE, Davis A, Brooke AM, Silverman M. Are all wheezing disorders in very young (preschool) children increasing in prevalence? Lancet. 2001;357:1821-5.
26. Oldaeus G, Anjou K, Björkstén B, Moran JR, Kjellman NI. Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Arch Dis Child. 1997;77:4-10.
27. Høst A, Koletzko B, Dreborg S, Muraro A, Wahn U, Aggett P, Bresson JL, Hernell O, Lafeber H, et al. Dietary products used in infants for treatment and prevention of food allergy. Joint Statement of the European Society for Paediatric Allergology and Clinical Immunology (ESPACI) Committee on Hypoallergenic Formulas and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Committee on Nutrition. Arch Dis Child. 1999;81:80-4.
28. Committee on Nutrition, American Academy of Pediatrics. Hypoallergenic infant formulas. Pediatrics. 2000;106:346-9.
29. Halken S, Hansen KS, Jacobsen HP, Estmann A, Faelling AE, Hansen LG, Kier SR, Lassen K, Lintrup M, et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatr Allergy Immunol. 2000;11:149-61.
30. Arshad SH, Bateman B, Sadeghnejad A, Gant C, Matthews SM. Prevention of allergic disease during childhood by allergen avoidance: the Isle of Wight prevention study. J Allergy Clin Immunol. 2007;119:307-13.
31. von Berg A, Koletzko S, Filipiak-Pittroff B, Laubereau B, Grübl A, Wichmann HE, Bauer CP, Reinhardt D, Berdel D. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three-year results of the German Infant Nutritional Intervention Study. J Allergy Clin Immunol. 2007;119:718-25.
32. von Berg A. The concept of hypoallergenicity for atopy prevention. Nestle Nutr Workshop Ser Pediatr Program. 2007;59:49-57, 57-62.
33. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001;357:1076-9.
34. Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003;361:1869-71.
35. Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M. Probiotics and prebiotic galactooligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:192-8.
36. Abrahamsson TR, Jakobsson T, Böttcher MF, Fredrikson M, Jenmalm MC, Björkstén B, Oldaeus G. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:1174-80.
37. Björksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and intestinal flora during the first year of life. J Allergy Clin Immunol. 2001;108:516-20.
38. Penders J, This C, Vink C, Stelma FF, Snijders B, Kummeling I, van den Brandt PA, Stobberingh EE. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 2006;118:511-21.
39. Vos AP, Haarman M, Buco A, Govers M, Knol J, Garssen J, Stahl B, Boehm G, M'Rabet L. A specific prebiotic oligosaccharide mixture stimulates delayed-type hypersensitivity in a murine influenza vaccination model. Int Immunopharmacol. 2006;6:1277-86.
40. Vos AP, Haarman M, van Ginkel J-WH, Knol J, Garssen J, Stahl B, Boehm G, M'Rabet L. Dietary supplementation of neutral and acidic oligosaccharides enhances Th1-dependent vaccination responses in mice. Pediatr Allergy Immunol. 2007;18:304-12.
41. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol. 2007;119:184-91.
42. Wahn U, von Mutius E, Lau S, Nickel R. The development of atopic phenotypes: genetic and environmental determinants. Nestlé Nutr Workshop Ser Pediatr Program. 2007;59:1-15.
43. Ly NP, Gold DR, Weiss ST, Celedón JC. Recurrent wheeze in early childhood and asthma among children at risk for atopy. Pediatrics. 2006;117:e1132-8.
44. Saglani S, Payne DN, Zhu J, Wang Z, Nicholson AG, Bush A, Jeffery PK. Early detection of airway wall remodelling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med. 2007;176:858-64.
45. Ouwehand AC, Isolauri E, He F, Hashimoto H, Benoo Y, Salimine S. Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol. 2001;108:144-5.
46. Kalliomäki M, Isolauri E. Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol. 2003;3:15-20.
47. Watzl B, Girrbach S, Roller M. Inulin, oligofructose and immunomodulation. Br J Nutr. 2005;93 Suppl 1:S49-55.
48. Vos AP, M'Rabet L, Stahl B, Boehm G, Garssen J. Immune modulatory effects and potential working mechanisms of orally applied non-digestible carbohydrates. Crit Rev Immunol. 2007;27:97-140.